The recent article by Ackermans et al., published in Biomedical Chromatography [1] , describes the liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based determination of five thyroid hormone (TH) metabolites (T 4 , T 3 , rT 3 , 'rT 2 ' [i.e., 3,5-T 2 ], and T 2 [3,3´-T 2 ]) within one analytical run in samples from different tissues. The aim of the article is to use this technique to better understand tissue-specific TH metabolism. Unfortunately, the authors used an unusual and even misleading abbreviation for 3,5-T 2 (they call it "rT 2 "). In the context that rT 3 is frequently used as abbreviation for the 'reverse' 3,3´,5´-triiodothyronine isomer, which is devoid of T 3 -like thyromimetic activity, one would intuitively assume that "rT 2 " might be a direct 3-deiodination product of rT 3 . However, this is chemically impossible and not the case because 3,5-T 2 , named "rT 2 " by the authors can only be formed from T 3 by 3´-deiodination. Only two endogenous hormones, namely T 4 and T 3 , were detected above the limit of quantification in the tissue samples analyzed; however, the detection of other endogenous TH metabolites would be desirable. Further preanalytical sample workup www.expert-reviews.com
Key Paper Evaluation
Key issues• A liquid chromatography-tandem mass spectrometry method was used to measure five thyroid hormone (TH) metabolites in one analytical run. • Four deuterated standards were used for the validation of TH quantification.• T 4 and T 3 were detected only qualitatively but not quantified in tested rat tissue samples; other metabolites were not detected at all.• The possibility to link tissue TH levels to local iodothyronine deiodinase expression is proposed.• However, the issues relating to the contribution of carrier-mediated TH import and export to local concentration analyzed are not addressed.